EIN Presswire is now on Substack! Follow for customer spotlights, interviews, gossip and more!

EIN Presswire is now on Substack! Follow for customer spotlights, interviews, gossip and more!

World Media Directory · RSS · Email Newsletters

There were 1,080 press releases posted in the last 24 hours and 402,332 in the last 365 days.

Press Releases on August 10, 2023

1,534 Press Releases

Published on August 10, 2023 - 20:03 GMT

Sientra Reports Record Second Quarter Financial and Operational Results

Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement in operating cash flow and adjusted EBITDA respectively Continued …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:02 GMT

Trisura Group Reports Second Quarter 2023 Results

TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the second quarter of 2023. David Clare, President and CEO of Trisura, …

Distribution channels: Business & Economy, Insurance Industry ...
Published on August 10, 2023 - 20:02 GMT

AirAnswers® and Canna Klean Join Forces to Identify and Remediate Biological Contamination in Cannabis Cultivation Facilities

CHICAGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Canna Klean & and AirAnswers® are excited to announce their partnership that will provide the cannabis industry with solutions to cannabis facility contamination and passing of compliance testing. Certain …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:02 GMT

Aptose Reports Results for the Second Quarter 2023

─ CRc Response Rate 50% with Tuspetinib/Venetoclax Doublet in Evaluable Patients ─ ─ CRc 44% in Patients Who Failed Prior Venetoclax ─ ─ CRc 43% in Patients with Wildtype FLT3 ─ ─ CRc 67% in Patients with Mutated FLT3 ─ ─ Data Guide to …

Distribution channels: Business & Economy, Technology ...
Published on August 10, 2023 - 20:01 GMT

Kennedy Ulcer: End-of-life Decubitus Ulcer

We must examine if a decubitus ulcer was unavoidable and if the patient received the necessary treatment and service. SANTA BARBARA , CALIFORNIA , UNITED STATES , August 10, 2023 /⁨EINPresswire.com⁩/ -- “The committee members then investigated how long …

Distribution channels: Business & Economy, Consumer Goods ...
Published on August 10, 2023 - 20:01 GMT

Erasca Reports Second Quarter 2023 Financial Results and Business Updates

Significant progress across all clinical programs including Phase 1b combo data for ERAS-007 and ERAS-601, FTD and ODD granted for ERAS-801, and publication of naporafenib combination data Multiple meaningful clinical catalysts over the next 18 months and …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

Ventyx Biosciences Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Progress

Completed enrollment in the Phase 2 trial of VTX002 (S1P1R modulator) in ulcerative colitis and the Phase 2 trial of VTX958 (TYK2 inhibitor) in plaque psoriasis, with topline readouts expected in Q4 2023 Initiated a Phase 1 trial of VTX3232, a novel CNS- …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2023 Financial Results

Obtained U.S. FDA IND clearance for ONCT-534, our dual-action androgen receptor inhibitor, for the treatment of patients with advanced prostate cancer who are resistant to approved androgen receptor signaling inhibitors Dosed the first patient in our Phase …

Distribution channels: Business & Economy, Technology ...
Published on August 10, 2023 - 20:01 GMT

ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update

Advancing Phase 2/3 ASPEN-06 gastric cancer trial with data update expected in Q423 Terminating azacitidine combination development programs: ASPEN-02 in MDS and ASPEN-05 in AML Continuing focus on combinations with anti-cancer antibodies, antibody- …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights

Reported positive initial Phase 1 VYD222 clinical trial data, including favorable safety data and robust serum neutralizing titers from all three dose levels tested Plans to pursue rapid initiation of a 750-participant pivotal clinical trial of VYD222 ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates

NEXI-001 data presented at ASCO 2023 demonstrates proof-of-concept in patients with relapsed AML after allogeneic hematopoietic cell transplantation (HCT) and refractory to additional chemotherapy or salvage treatments; one patient continues to show no …

Distribution channels: Business & Economy, Technology ...
Published on August 10, 2023 - 20:01 GMT

AVITA Medical Reports Second Quarter Financial Results

VALENCIA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

Total Q2 revenue of $12.0 million and net income of $4.6 million Product sales and royalty revenue of $6.5 million up 175% from Q2 2022 and 22% from Q1 2023 $21.6 million of cash on hand Launched Betaine Anhydrous Management to hold conference call today …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

Core Molding Technologies Presenting at the 14th Annual Midwest IDEAS Investor Conference on August 24th in Chicago, IL

COLUMBUS, Ohio, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on August 10, 2023 - 20:01 GMT

Teknova Reports Second Quarter 2023 Financial Results

Second quarter 2023 total revenue was $11.5 million, up 26% sequentially Received certification of new state-of-the-art facility for production of GMP-grade products Company revises 2023 revenue guidance to $37-40 million, continues to anticipate free cash …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 10, 2023 - 20:01 GMT

Gevo Reports Second Quarter 2023 Financial Results

ENGLEWOOD, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the second quarter of 2023 and recent corporate highlights. Recent Corporate Highlights Net- …

Distribution channels: Business & Economy ...
Published on August 10, 2023 - 20:01 GMT

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $1.6 million Ended Q2 2023 with cash, cash equivalents and short-term investments of $102.9 million Company to host investor conference call and webcast today, Thursday, August 10, at 4:30pm ET BURLINGTON, Mass., Aug. 10, …

Distribution channels: Business & Economy, Technology ...
Published on August 10, 2023 - 20:01 GMT

SurgePays Announces Record Second Quarter 2023 Financial Results

Net income of $6.0 million Revenue of $35.9 million EPS of $0.42 $6.4 million EBITDA Gross profit margin increased to 27.9% BARTLETT, Tenn., Aug. 10, 2023 (GLOBE NEWSWIRE) -- SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and …

Distribution channels: Business & Economy, Media, Advertising & PR ...
Published on August 10, 2023 - 20:01 GMT

Mercado Libre appoints new CFO

MONTEVIDEO, Uruguay, Aug. 10, 2023 (GLOBE NEWSWIRE) -- MercadoLibre, Inc. (Nasdaq: MELI)—the leading technology company in e-commerce and financial services in Latin America—announced today the appointment of Martín de los Santos as its new CFO. The …

Distribution channels: Companies, Retail ...
Published on August 10, 2023 - 20:01 GMT

SPAR Group, Inc. Announces Timing of Second Quarter Fiscal 2023 Results Conference Call

AUBURN HILLS, Mich., Aug. 10, 2023 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), a leading global provider of merchandising and marketing services, today announces that it will release its fiscal second …

Distribution channels: Culture, Society & Lifestyle, Retail ...

Previous 9 10 11 12 13 14 15 16 17 18 19 Next

Previous Day 2023 Calendar Next Day